Dr. O'Leary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 860
Dallas, TX 75246Phone+1 214-820-8500Fax+1 214-820-0993
Education & Training
- Massachusetts General HospitalFellowship, Gastroenterology, 2002 - 2005
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1999 - 2002
- University of California San Francisco School of MedicineClass of 1999
Certifications & Licensure
- TX State Medical License 2001 - 2026
- MA State Medical License 2003 - 2007
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Publications & Presentations
PubMed
- 77 citationsPrediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort.Jasmohan S. Bajaj, K. Rajender Reddy, Puneeta Tandon, Florence Wong, Patrick S. Kamath
The American Journal of Gastroenterology. 2018-04-01 - 37 citationsModel for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease.Naveed Sarmast, Gerald O. Ogola, Maria Kouznetsova, Michael D. Leise, Ranjeeta Bahirwani
Hepatology. 2020-11-01 - 630 citationsLedipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis
Gastroenterology. 2015-09-01
Press Mentions
- Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver TransplantationMarch 1st, 2017
Committees
- Member, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) 2016 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: